BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3065215)

  • 1. Immunopathology of thrombocytopenia in experimental malaria.
    Grau GE; Piguet PF; Gretener D; Vesin C; Lambert PH
    Immunology; 1988 Dec; 65(4):501-6. PubMed ID: 3065215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.
    Grau GE; Piguet PF; Engers HD; Louis JA; Vassalli P; Lambert PH
    J Immunol; 1986 Oct; 137(7):2348-54. PubMed ID: 3093572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of the delayed phase of Rauscher virus-induced thrombocytopenia.
    Grau GE; Morrow D; Izui S; Lambert PH
    J Immunol; 1986 Jan; 136(2):686-91. PubMed ID: 3455704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia associated with the induction of neonatal tolerance to alloantigens: immunopathogenic mechanisms.
    Merino J; Qin HY; Schurmans S; Gretener D; Grau GE; Lambert PH
    Eur J Immunol; 1989 Sep; 19(9):1693-9. PubMed ID: 2792184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cerebral malaria by adoptive transfer of malaria-specific cultured T cells into mice infected with Plasmodium berghei.
    Finley R; Weintraub J; Louis JA; Engers HD; Zubler R; Lambert PH
    J Immunol; 1983 Sep; 131(3):1522-6. PubMed ID: 6224859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria.
    van der Heyde HC; Elloso MM; Chang WL; Kaplan M; Manning DD; Weidanz WP
    J Immunol; 1995 Apr; 154(8):3985-90. PubMed ID: 7706737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune thrombocytopenia in recurrent polietiological malaria (Plasmodium falciparum, Plasmodium vivax)].
    Panasiuk A
    Wiad Parazytol; 2001; 47(1):85-9. PubMed ID: 16888956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection.
    Cunha-Rodrigues M; Portugal S; Febbraio M; Mota MM
    Malar J; 2007 Mar; 6():32. PubMed ID: 17367535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
    Jayawardena AN; Murphy DB; Janeway CA; Gershon RK
    J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet antibody activity in malaria thrombocytopenia].
    Touze JE; Mercier P; Rogier C; Hovette P; Schmoor P; Dabanian C; Campiadgi S; Laroche R
    Pathol Biol (Paris); 1990 Sep; 38(7):678-81. PubMed ID: 2235082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in platelet survival and total platelet sialic acid concentration in rats infected with Plasmodium bergei bergei.
    Inyang AL; Okpako D; Essien EM
    Afr J Med Med Sci; 1995 Mar; 24(1):41-6. PubMed ID: 7495199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of immunity to Plasmodium berghei with spleen cells from drug cured mice.
    Yadav M; Sidhu AS
    Southeast Asian J Trop Med Public Health; 1982 Jun; 13(2):186-95. PubMed ID: 6755741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell- rather than antibody-mediated immunity leads to the development of profound thrombocytopenia during experimental Plasmodium berghei malaria.
    Gramaglia I; Sahlin H; Nolan JP; Frangos JA; Intaglietta M; van der Heyde HC
    J Immunol; 2005 Dec; 175(11):7699-707. PubMed ID: 16301680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early lymphocyte trapping in malaria infections: a particulate antigen mediated phenomenon.
    Lewis-Hughes PH; Howell MJ
    J Parasitol; 1984 Jun; 70(3):391-7. PubMed ID: 6387079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4-dependent mechanisms prevent T cell induced-liver pathology during the erythrocyte stage of Plasmodium berghei malaria.
    Jacobs T; Plate T; Gaworski I; Fleischer B
    Eur J Immunol; 2004 Apr; 34(4):972-80. PubMed ID: 15048707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia and human immunodeficiency virus in children.
    Ellaurie M; Burns ER; Bernstein LJ; Shah K; Rubinstein A
    Pediatrics; 1988 Dec; 82(6):905-8. PubMed ID: 3186382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunological response of CBA mice to P. yoelii. I. General characteristics, the effects of T-cell deprivation and reconstitution with thymus grafts.
    Jayawardena AN; Targett GA; Carter RL; Leuchars E; Davies AJ
    Immunology; 1977 Jun; 32(6):849-59. PubMed ID: 328382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression in murine malaria: suppressor role of macrophages and their products during acute and chronic Plasmodium berghei infection.
    Wangoo A; Ganguly NK; Mahajan RC
    APMIS; 1990 May; 98(5):407-14. PubMed ID: 2141476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.